These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 692815)

  • 41. Effects of 6-hydroxydopamine or 5,7-dihydroxy-tryptamine on the development of physical dependence on ethanol.
    Frye GD; Ellis FW
    Drug Alcohol Depend; 1977; 2(5-6):349-59. PubMed ID: 562250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of selective destruction of serotonergic neurons in nucleus raphe magnus on morphine-induced antinociception.
    Mohrland JS; Gebhart GF
    Life Sci; 1980 Dec 22-29; 27(25-26):2627-32. PubMed ID: 7219034
    [No Abstract]   [Full Text] [Related]  

  • 43. Interaction of 5,6- and 5,7-dihydroxytryptamine with tissue monoamine oxidase.
    Klemm HP; Baumgarten HG
    Ann N Y Acad Sci; 1978 Jun; 305():36-56. PubMed ID: 280252
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 45. 5,7-DHT-induced muricide: inhibition as a result of preoperative exposure of rats to mice.
    Marks PC; O'Brien M; Paxinos G
    Brain Res; 1977 Oct; 135(2):383-8. PubMed ID: 562701
    [No Abstract]   [Full Text] [Related]  

  • 46. The behavioral effects of depletions of brain serotonin induced by 5,7-dihydroxytryptamine vary with time after administration.
    Gately PF; Segal DS; Geyer MA
    Behav Neural Biol; 1986 Jan; 45(1):31-42. PubMed ID: 3954713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
    Erinoff L; Snodgrass SR
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
    Kamei J; Ogawa M; Kasuya Y
    Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity.
    Lucot JB; Seiden LS
    Psychopharmacology (Berl); 1982; 77(2):114-6. PubMed ID: 6812128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of intracerebroventricular 5,7-dihydroxytryptamine on morphine analgesia is time-dependent.
    Romandini S; Pich EM; Esposito E; Kruszewska AZ; Samanin R
    Life Sci; 1986 Mar; 38(10):869-75. PubMed ID: 3951313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tail temperature in rats after intraventricular injections of 6-hydroxydopamine or 5,7-dihydroxytryptamine.
    Ishikawa Y; Matuszek M; Nakayama T
    Neurosci Lett; 1980 Nov; 20(2):177-81. PubMed ID: 7443067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Injection of 5,7-dihydroxytryptamine into the B3 raphe region of neonatal rat pups induces hyperalgesia but only slight alterations in ingestion-related behaviors.
    Enters EK; Specht SM; Spear LP
    Behav Neural Biol; 1990 Mar; 53(2):244-57. PubMed ID: 1691912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rotational responses to serotonergic and dopaminergic agonists after unilateral dihydroxytryptamine lesions of the medial forebrain bundle: co-operative interactions of serotonin and dopamine in neostriatum.
    Waddington JL; Crow TJ
    Life Sci; 1979 Oct; 25(15):1307-14. PubMed ID: 316093
    [No Abstract]   [Full Text] [Related]  

  • 54. Selective demonstration of serotonergic neurons and terminals in electron micrographs: loading with 5,7-dihydroxytryptamine and fixation with NaMnO4.
    Gershon MD; Sherman D
    J Histochem Cytochem; 1982 Aug; 30(8):769-73. PubMed ID: 7119420
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
    Fischette CT; Nock B; Renner K
    Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of 5,7-dihydroxytryptamine on the concentration of individual proteins in different areas of the rat brain.
    Heydorn WE; Creed GJ; Nguyen KQ; Jacobowitz DM
    Brain Res; 1986 Mar; 368(1):193-6. PubMed ID: 3006866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
    Pranzatelli MR; Rubin G; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancement of footshock-induced analgesia by spinal 5,7-dihydroxytryptamine lesions.
    Hutson PH; Tricklebank MD; Curzon G
    Brain Res; 1982 Apr; 237(2):367-72. PubMed ID: 7083000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5,7-Dihydroxytryptamine as a tool to study the functional role of central 5-hydroxytryptamine neurons.
    Fuxe K; Ogren SO; Agnati LF; Jonsson G; Gustafsson JA
    Ann N Y Acad Sci; 1978 Jun; 305():346-69. PubMed ID: 280251
    [No Abstract]   [Full Text] [Related]  

  • 60. Hippocampal cell nuclear binding of corticosterone following 5,7-dihydroxytryptamine.
    Siegel RA; Weidenfeld J; Chen M; Feldman S; Melamed E; Chowers I
    Mol Cell Endocrinol; 1983 Aug; 31(2-3):253-9. PubMed ID: 6195032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.